Security key
21077P108
Context Therapeutics Inc. - Common Stock (CNTX)
CUSIP: 21077P108
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 91,741,639
- Total 13F shares
- 57,034,586
- Share change
- +53,099,609
- Total reported value
- $114,325,460
- Price per share
- $2.00
- Number of holders
- 34
- Value change
- +$107,182,399
- Number of buys
- 27
- Number of sells
- 12
Report period
Q2 2024
Institutions
34
Top holders
10
CNTX full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Context Therapeutics Inc. SEC filings
Context Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 21077P108
Recent filing periods:
Top shareholders of CNTX - Context Therapeutics Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. |
13F
|
Company |
1.2%
|
1,108,357
|
$1,529,533 | — | 31 Mar 2024 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.79%
|
725,951
|
$1,001,812 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.65%
|
598,303
|
$825,658 | — | 31 Mar 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.36%
|
328,817
|
$453,767 | — | 31 Mar 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.32%
|
296,675
|
$409,412 | — | 31 Mar 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.22%
|
205,934
|
$284,189 | — | 31 Mar 2024 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.14%
|
125,852
|
$174,000 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
105,809
|
$146,016 | — | 31 Mar 2024 | |
| Mill Creek Capital Advisors, LLC |
13F
|
Company |
0.11%
|
104,631
|
$144,391 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
101,072
|
$139,547 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.04%
|
39,900
|
$55,000 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
37,219
|
$51,362 | — | 31 Mar 2024 | |
| Clear Harbor Asset Management, LLC |
13F
|
Company |
0.04%
|
36,000
|
$49,680 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
32,907
|
$45,412 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
22,389
|
$30,897 | — | 31 Mar 2024 | |
| SHEETS SMITH WEALTH MANAGEMENT |
13F
|
Company |
0.02%
|
20,000
|
$27,600 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
15,041
|
$20,757 | — | 31 Mar 2024 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.01%
|
11,453
|
$15,805 | — | 31 Mar 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.01%
|
10,261
|
$14,160 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
6,357
|
$8,773 | — | 31 Mar 2024 | |
| Tarek Sahmoud |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
35,000
mixed-class rows
|
$8,415 | — | 16 Aug 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
1,500
|
$2,070 | — | 31 Mar 2024 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
400
|
$552 | — | 31 Mar 2024 | |
| Retirement Group, LLC |
13F
|
Company |
0%
|
155
|
$214 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
116
|
$160 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
33
|
$46 | — | 31 Mar 2024 | |
| Richard J. Berman |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 13 Jun 2024 | |
| Evan G. Dick |
3/4/5
|
Former Section 16 officer |
—
class O/S missing
|
29,223
|
— | — | 15 Feb 2022 | |
| William F. Rencher |
3/4/5
|
Former Section 16 officer |
—
class O/S missing
|
8,000
|
— | — | 15 Feb 2022 |
Institutional Holders of Context Therapeutics Inc. - Common Stock (CNTX) as of Q2 2024
As of 30 Jun 2024,
Context Therapeutics Inc. - Common Stock (CNTX) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,034,586 shares.
The largest 10 holders included
GREAT POINT PARTNERS LLC, Deep Track Capital, LP, Nextech Invest Ltd., Avidity Partners Management LP, Blue Owl Capital Holdings LP, VANGUARD GROUP INC, Driehaus Capital Management LLC, Nantahala Capital Management, LLC, Alyeska Investment Group, L.P., and Ally Bridge Group (NY) LLC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
25
Q2 2024 holders
34
Holder diff
9
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.